Literature DB >> 15308872

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA.

H-P Török1, J Glas, R Gruber, V Brumberger, C Strasser, H Kellner, E Märker-Hermann, C Folwaczny.   

Abstract

AIMS: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e.g. antibodies against Saccharomyces cerevisiae (ASCA), antibodies against exocrine pancreas (PAB) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) are present in HLA-B27-associated SpA.
METHODS: 87 patients with HLA-B27-positive SpA and 145 controls were tested for ASCA, PAB and pANCA employing ELISA or indirect immunofluorescence, respectively. Antibody-positive patients were interviewed regarding IBD-related symptoms using a standardized questionnaire. RESULTS/
CONCLUSION: When compared to the controls, ASCA IgA but not ASCA IgG levels were significantly increased in patients with SpA, in particular in ankylosing spondylitis (AS) and undifferentiated SpA (uSpA). pANCA were found in increased frequency in patients with SpA whereas PAB were not detected. The existence of autoantibodies was not associated with gastrointestinal symptoms but sustains the presence of a pathophysiological link between bowel inflammation and SpA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308872     DOI: 10.1159/000080081

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

1.  Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.

Authors:  Wahiba Sakly; Moncef Jeddi; Ibtissem Ghedira
Journal:  Dig Dis Sci       Date:  2007-11-30       Impact factor: 3.199

Review 2.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

3.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

4.  Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.

Authors:  Franck Biet; Laurent Gendt; Eric Anton; Eric Ballot; Jean-Pierre Hugot; Catherine Johanet
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

5.  Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.

Authors:  Matthew L Mundwiler; Ling Mei; Carol J Landers; John D Reveille; Stephan Targan; Michael H Weisman
Journal:  Arthritis Res Ther       Date:  2009-11-23       Impact factor: 5.156

Review 6.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

7.  Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis.

Authors:  Mark J Asquith; Patrick Stauffer; Sean Davin; Claire Mitchell; Phoebe Lin; James T Rosenbaum
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

8.  Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.

Authors:  S Desplat-Jégo; C Johanet; A Escande; J Goetz; N Fabien; N Olsson; E Ballot; J Sarles; J J Baudon; J C Grimaud; M Veyrac; P Chamouard; R L Humbel
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

9.  Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.

Authors:  Massimo-C Fantini; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 10.  Non-invasive investigation in patients with inflammatory joint disease.

Authors:  Elisabetta Dal Pont; Renata D'Incà; Antonino Caruso; Giacomo-Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.